The
European
Bifurcation
Club

Join us for the EBC 2024 meeting in
Frankfurt, Germany on the 4th & 5th October.

  • 00Days
  • 00Hours
  • 00Minutes

EBC ON-DEMAND

Watch a selection of individual EBC presentations and sessions from previous meetings. For updates and notifications please subscribe to the EBC channel.

Presentations

Download PDFs of presentations from previous EBC conferences.

EBC Meeting

For more information about the European Bifurcation Club meeting, click the button below.

EBC - Industry Partners

The EBC is gratefully sponsored by medical device, imaging and pharmaceutical

companies specialising in the field of PCI & bifurcation treatments.

Please contact us for more information on how to become a partner of the EBC 2024 meeting:

PLATINUM

The ABS® Modular Bifurcation System is a novel hybrid stent platform. The main-branch stent is oriented first towards the side branch before full deployment. The system is designed for automatic orientation and alignment of main branch and side branch (stents) with complete coverage of carina and side-branch access.

The ABS device is a modular, dual-catheter, independently movable system.


Bifurcating stent (for complete coverage of the 3 limbs), Bifurcation stent (for the main branch only), and Ostial stent (side-branch only free-standing) are in development based on this technology. Specially designed stents in consideration of the size of the left main bifurcation are also in development for both bifurcating and bifurcation stent deployments in the left main coronary arteries.


Visit our website to learn more.

Innovating and Delivering New Technologies.

 

Cordis is proud to have completed the acquisition of MedAlliance and its novel SELUTION SLR™ Drug-Eluting Balloon (DEB).

 

Using breakthrough proprietary technology, MedAlliance has found a unique solution to the challenge of controlled and sustained sirolimus release with the SELUTION SLR™ DEB.

 

Cordis and MedAlliance combined are committed to accelerating the development and commercialisation of innovative cardiovascular interventional products around the world.

 

Visit our website to learn more.

Bold thinking. Bolder actions. We are Medtronic.

We lead global healthcare technology and boldly attack the most challenging health problems facing humanity by searching out and finding solutions. 

Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ passionate people. 

Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. 

Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for all.

In everything we do, we are engineering the extraordinary.

Visit our website to learn more.

GOLD

Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.


We’re committed to advancing cardiology through less invasive technologies that improve outcomes, deliver care to more patients, reduce costs, and help millions live healthier lives.


FIND OUT MOREwww.bostonscientific.com

At Terumo Interventional Systems, we constantly work to refine our products so that interventionalists can do more.

 

 

That is why we are proud to be a sponsor of EBC and support great thinking that pushes forward the boundaries of our field. With our mission “Contributing to Society through Healthcare” for 100 years, we have been committed to innovation that embraces complexity.

 

Our exceptional tools and education programmes empower physicians with the confidence they need to perform ever-more challenging procedures and to spark progress.

 

 

Experience the quality difference of products designed in Japan.

 

 

FIND OUT MORE: https://www.terumo-europe.com

BRONZE

PARTICIPANT

According to EBC consensus documents, it is recommended to perform bifurcation PCI with provisional side branch stenting for the great majority of coronary bifurcation lesions. We recommend a meticulous procedural planning and execution of technical steps that ultimately aim at reconstructing the underlying bifurcation anatomy.